Morning Market Losers

by Benzinga Staff
September 10, 2012 9:55 AM | 29 seconds read

20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.

Geron (NASDAQ: GERN) fell 50.69% to $1.43 at 9:52 am. Geron announced that, on the basis of an unplanned interim analysis, it is discontinuing its randomized Phase 2 study of imetelstat in metastatic HER2-negative breast cancer.Nordion (NYSE: NDZ) shares dipped 39.06% to $6.49. Nordion announced its plans to suspend its quarterly dividend after an arbitration loss.Zalicus (NASDAQ: ZLCS) shares lost 26.62% to $1.02. Zalicus announced top line results from its Phase 2b clinical trial of Synavive® in rheumatoid arthritis.Synergy Pharmaceuticals (NASDAQ: SGYPU) dropped 25.52% to $11.15. Synergy Pharmaceuticals' 52-week trading range is $9.80-$15.88.

20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: NewsMovers & ShakersIntraday UpdateMarketsMorning Market Losers

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.